Missouri’s only abortion clinic to stay open after injunction issued
(Reuters) – The only abortion clinic in Missouri can stay open after a St. Louis judge issued a preliminary injunction on Monday saying the state must make an “official” decision…
by October Gallery
(Reuters) – The only abortion clinic in Missouri can stay open after a St. Louis judge issued a preliminary injunction on Monday saying the state must make an “official” decision…
(Reuters Health) – With increased access to insurance under the Affordable Care Act (ACA), known as Obamacare, fewer middle-aged people are dying from heart disease, a U.S. study suggests. Under…
(Reuters) – Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc’s continuous glucose monitoring system for three months compared…
(Reuters Health) – People with inflammatory bowel disease – either Crohn’s disease or ulcerative colitis – may incur health costs more than three times higher than individuals without these conditions,…
BOSTON (Reuters) – A federal judge on Friday tossed the convictions of a co-owner and former employee of a Massachusetts compounding pharmacy accused of conspiring to help it evade regulatory…
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo (Reuters) – Takeda Pharmaceutical Co Ltd said on Wednesday…
(Reuters Health) – U.S. soldiers are more likely to have poor heart health than civilians of similar ages, a new study finds. Comparing more than 263,000 active duty Army personnel…
(Reuters Health) – Middle schools that offer a comprehensive dating violence prevention program in every grade may have fewer youth involved in abusive relationships, a U.S. study suggests. The goal…
WASHINGTON (Reuters) – A top U.S. Senator signaled some support on Tuesday for legislation permanently placing illicit chemical knock-offs of the extremely potent opioid fentanyl into the same legal class…
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks,…